Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

Overview Of Cell Separation And Isolation

Overview Of Cell Separation And Isolation

Cell separation was first achieved in 1964 by S. H. Seal, who separated large tumor cells from the smaller blood cells using filtration. Two years later, Pohl and Hawk performed experiments on how cells respond differently to a nonuniform electric field based on the cell type. Such observations were the inception of cell separation methods, which allow isolating a single cell type from a heterogeneous sample.

Scale-Up Processes

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Standardized cryopreservation of human primary cells.

Current protocols in cell biology·2014

Same author

Standardized cryopreservation of pluripotent stem cells.

Current protocols in stem cell biology·2014

Same author

The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation.

Stem cells and development·2013

Same author

Commercialization of regenerative medicine: learning from spin-outs.

Rejuvenation research·2013

Same author

Cryopreservation and thawing of cells.

Current protocols in immunology·2012

Same author

Secretory protein profiling reveals TNF-α inactivation by selective and promiscuous Sec61 modulators.

Chemistry & biology·2011

Same journal

Dialysis bioreactor enables high-density, serum-free expansion of dental pulp-derived mesenchymal stromal cells with enhanced secretome.

Cytotherapy·2026

Same journal

Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?

Cytotherapy·2026

Same journal

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026

Same journal

Manufacturing strategies for prolonged CAR-T cell persistence.

Cytotherapy·2026

Same journal

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026

Same journal

Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.

Cytotherapy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 26, 2026

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Published on: December 12, 2019

Technological developments for small-scale downstream processing of cell therapies.

R Lee Buckler¹, Eric J Kunkel², Maria L Thompson²

¹RepliCel, Life Sciences, Inc., Vancouver, British Columbia, Canada.

|February 10, 2016

Summary

This summary is machine-generated.

Cell-based therapies are advancing despite challenges. Novel downstream processing technologies are crucial for efficient and reliable distribution from manufacturing to patients, making these therapies a reality.

More Related Videos

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

Related Experiment Videos

Last Updated: Mar 26, 2026

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Automated Counterflow Centrifugal System for Small-Scale Cell Processing

Published on: December 12, 2019

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

Area of Science:

Biotechnology
Regenerative Medicine
Cell Therapy Manufacturing

Background:

Cell-based therapies are increasingly prevalent, facing regulatory and clinical challenges.
Advancements in manufacturing and processing are essential for commercializing these therapies.
Efficient distribution is key to realizing the potential of cell therapies.

Purpose of the Study:

To highlight the importance of downstream processing in cell therapy development.
To discuss how modern technologies address distribution challenges.
To emphasize the role of small-scale solutions in advancing cell therapy accessibility.

Main Methods:

Review of current downstream processing technologies for cell therapies.
Analysis of innovations in manufacturing and distribution logistics.
Focus on small-scale solutions for enhanced efficiency and reliability.

Main Results:

Downstream processing technologies are critical for the successful scale-up and distribution of cell therapies.
Modern solutions improve the efficiency and reliability of delivering therapies to patients.
Small-scale downstream processing innovations are pivotal in bridging the gap between development and clinical application.

Conclusions:

Continued innovation in downstream processing is vital for the widespread adoption of cell-based therapies.
Technological advancements in manufacturing and distribution are overcoming key hurdles.
Small-scale solutions represent a significant step towards making cell therapies a clinical reality.